Past Meetings
Program
Program for The joint ICMS-AACR International Conference on Tumor Microenvironment March 6-10, 2007
Tuesday, March 6, 2007 (Palazzo Vecchio)
Opening Session
19:00 Greetings:
Isaac P. Witz, Tel Aviv, Israel, President, International Cancer Microenvironment Society
Margaret Foti, Philadelphia, USA, Chief Executive Officer, American Association for Cancer Research
Raffaella Giavazzi, Bergamo, Italy, President, Italian Cancer Society
19:30 Opening lecture
Alberto Mantovani, Milan, Italy MOLECULAR LINKS BETWEEN INFLAMMATION AND CANCER
20:15 Welcome Reception
Wednesday, March 7, 2007
Plenary Session I - Gene Expression Regulation in the Tumor Microenvironment -Auditorium
Session dedicated to the memory of Raphael Kafka
Chairperson: Eitan Yefenof
08:30 Menashe Bar-Eli, Houston, TX, USA TRANSCRIPTIONAL REGULATION IN MELANOMA PROGRESSION: IMPLICATIONS FOR THERAPY
08:55 Hans Clevers, Utrecht, The Netherlands Wnt AND Notch COOPERATE TO MAINTAIN PROLIFERATIVE COMPARTMENTS IN CRYPTS AND INTESTINAL NEOPLASIA
09:20 Avraham Raz, Detroit, MI, USA DOWN-REGULATION OF PHOSPHOGLUCOSE ISOMERASE/AUTOCRINE MOTILITY FACTOR RESULTS IN MESENCHYMAL-TO-EPITHELIAL TRANSITION OF HUMAN LUNG FIBROSARCOMA CELLS
09:45 Yoel Kloog, Tel Aviv, Israel THE PALMITATES AND THE HYPERVARIABLE REGION OF H-Ras: RASOSOMES, H-Ras/GALECTIN-1 COMPLEX FORMATION, TRAFFICKING AND SIGNALING
10:10 Margareta M. Müller, Heidelberg, Germany
MOLECULAR NETWORKS THAT ACTIVATE THE TUMOR MICROENVIRONMENT AND PROMOTE TUMOR PROGRESSION
10:35 Valerie M. Weaver, Philadelphia, PA, USA SPATIAL-MECHANICAL REGULATION OF MALIGNANT TRANSFORMATION AND TREATMENT RESPONSE
11:00-11:30 – Coffee
Plenary Session II - Inflammatory Reactions in the Tumor Microenvironment -
Auditorium
Session dedicated to the memory of Jacqueline Seroussi
Chairperson: Margaret Foti
11:30 Frances Balkwill, London, UK MODIFYING THE INFLAMMATORY CYTOKINE NETWORK OF HUMAN CANCER
11:55 Giorgio Trinchieri, Frederick, MD, USA TOLL-LIKE RECEPTOR SIGNALING IN HEMATOPOIETIC AND NON-HEMATOPOIETIC CELLS: ROLE IN CANCER
12:20 Jeffrey W. Pollard, Bronx, NY, USA TUMOR-EDUCATED MACROPHAGES PROMOTE TUMOR PROGRESSION AND ENHANCE METASTASIS
12:45 Lisa M. Coussens, San Francisco, CA, USA INFLAMMATION, HUMORAL IMMUNITY AND CANCER DEVELOPMENT
13:10-14:30 – Lunch
Plenary Session III - Immune Functions in the Tumor Microenvironment -
Auditorium
Session dedicated to the memory of Diana Mary and Dr. Stanley Steyer
Chairperson: Raffaella Giavazzi
14:30 Ron N. Apte, Beer Sheba, Israel THE IMPORTANCE OF MOLECULES OF THE IL-1 FAMILY IN CARCINOGENESIS AND TUMOR INVASIVENESS
14:55 Theresa L. Whiteside, Pittsburgh, PA, USA TUMOR-DERIVED MICROVESICLES AND THEIR BIOLOGIC EFFECTS: ANOTHER WAY FOR TUMORS TO ESCAPE FROM THE IMMUNE SYSTEM
15:20 Wolf H. Fridman, Paris, France LOCAL IMMUNE CONTEXTURE, METASTASIS AND SURVIVAL IN COLORECTAL CANCER
15:45 Richard Bankert, Buffalo, NY, USA IN SITU TARGETING OF QUIESCENT HUMAN TUMORASSOCIATED MEMORY T CELLS IN THE TUMOR MICROENVIRONMENT FOR RE-ACTIVATION AND TUMOR KILLING: A THERAPEUTIC STRATEGY
16:10 Sharon Evans, Buffalo, NY, USA LOCAL MICROENVIRONMENTAL CONTROL OF CD8 T CELL TRAFFICKING WITHIN THE TUMOR MICROENVIRONMENT
16:35-17:00 -Coffee
Plenary Session IV - Tumor-Associated Stroma and Extracellular Matrix -
Auditorium
Chairperson: Angelo Messina
17:00 Lynn Matrisian, Nashville, TN, USA
THE MATRIX METALLOPROTEINASES AS MEDIATORS OF TUMOR: HOST COMMUNICATION
17:25 Harold L. Moses, Nashville, TN, USA STROMAL AND EPITHELIAL TGF-ß SIGNALING IN CANCER
17:50 Israel Vlodavsky, Haifa, Israel THE IMPACT OF HEPARANASE ON TUMOR METASTASIS AND ANGIOGENESIS
20:30 – Conference Dinner
Thursday, March 8, 2007
Symposium I – Local Tumor Immunity -Auditorium
Chairperson: Eva Klein
08:30 Luca Vannucci, Prague, Czech Republic A PARADOXICAL HYPOTHESIS: MIGHT A CONTROLLED IMMUNE SUPPRESSION HELP TO RESCUE THE IMMUNE RESPONSE IN A PRO-INFLAMMATORY TUMOR MICRO-ENVIRONMENT?
08:42 Karin Jöhrer, Innsbruck, Austria MYELOMA-DERIVED CHEMOKINES AND THEIR IMPACT ON IMMUNE CELL HOMEOSTASIS AND RESPONSE
08:54 Janet E. Price, Houston, TX, USA CXCL12 AS A MEDIATOR OF INTERACTIONS BETWEEN BREAST CANCER CELLS AND THE BONE MICROENVIRONMENT
09:06 Beatriz Arteta, Bizkaia, Spain TUMOR-ACTIVATED ENDOTHELIAL MANNOSE RECEPTOR CONTRIBUTES TO REGIONAL IMMUNE TOLERANCE DURING EXPERIMENTAL COLON CARCINOMA METASTASIS TO THE LIVER
09:18 Milada Sirova, Prague, Czech Republic IMMUNOSTIMULATORY EFFECT OF HPMA-BASED POLYMERIC CONJUGATE IN TUMOUR TREATMENT
09:30 Stephanie Darmanin, Sapporo, Japan ALL-TRANS RETINOIC ACID ENHANCES MURINE DENDRITIC CELL MIGTATION TO DRAINING LYMPH NODES VIA THE BALANCE OF MATRIX METALLOPROTEINASES AND THEIR INHIBITORS
Symposium II – Angiogenesis and Transendothelial Migration -Auditorium
Chairperson: Menashe Bar-Eli
09:45 Elena Voronov, Beer-Sheva, Israel TUMOR-DERIVED INTERLEUKIN-1 BETA IS A MAJOR FACTOR IN TUMOR ANGIOGENESIS
09:57 Jin Chen, Nashville, TN, USA A CRITICAL ROLE OF EphA2 RECEPTOR TYROSINE KINASE IN TUMOR ANGIOGENESIS
10:09 Ido Nevo, Tel-Aviv, Israel THE INVOLVEMENT OF FRACTALKINE IN BONE-MARROWENDOTHELIUM TRANSMIGRATION OF NEUROBLASTOMA CELLS
10:21 Irene F. Newsham, Houston, TX, USA DISSECTING THE EXTRAVASATION PROCESS OF METASTATIC BREAST CANCER CELLS USING AN ELECTRIC CELL SUBSTRATE IMPEDANCE SYSTEM (ECIS) ASSAY
10:33 Ashleigh Hill, Belfast, Northern Ireland, UK CD44 REGULATES THE EXPRESSION OF THE PROTEASES CATHEPSIN K AND MT1-MMP IN BREAST CANCER CELLS: IMPLICATIONS FOR METASTASIS TO BONE
10:45 Suzanne McFarlane, Belfast, Northern Ireland, UK CORTACTIN AND PAXILLIN ARE KEY INTERMEDIATES IN CD44INITIATED INTEGRIN MEDIATED ADHESION OF BREAST CANCER CELLS TO BONE MARROW ENDOTHELIUM
10:57 Michael E. Maragoudakis, Patras, Greece NEW INSIGHTS INTO THE ROLE OF THROMBIN IN ANGIOGENESIS AND TUMOR PROGRESSION
11:10-11:30 – Coffee
Symposium III – Targeting Tumor – Microenvironment Interactions –
Sala Verde
Chairperson: Wolf H. Fridman
08:30 Youcef M. Rustum, Buffalo, NY, USA MODULATION OF TUMOR MICROENVIRONMENT BY SELENIUM CORRELATES WITH ENHANCED THERAPEUTIC EFFICACY
08:50 Mark Pines, Bet Dagan, Israel INHIBITION OF FIBROBLAST TO MYOFIBROBLAST TRANSITION BY HALOFUGINONE CONTRIBUTE TO THE CHEMOTHERAPYMEDIATED ANTI-TUMORAL EFFECT
09:02 Eva Corey, Seattle, WA, USA TREATMENT OF OSTEOBLASTIC METASTASES OF PROSTATE CANCER WITH ANTI-RESORPTIVE AGENTS DECREASES TUMOR GROWTH
09:14 Irit Gil-Ad, Petah-Tiqva, Israel EVIDENCE FOR THE ANTI-TUMOR ACTIVITY OF THE ANTIDEPRESSANT SERTRALINE AGAINST SENSITIVE AND MULTI DRUG RESISTANT CANCER CELLS AND IN A MICE COLON CARCINOMA MODEL
09:26 Gary Acton, London, UK REVIEW OF PHASE II STUDIES OF THE VASCULAR DISRUPTING AGENT DMXAA (AS1404) IN COMBINATION WITH CHEMOTHERAPY
09:38 Clarisa Salado, Bizkaia, Spain ANTIMETASTATIC INTERVENTION SITES FOR RESVERATROL IN THE INFLAMMATORY MICROENVIRONMENT GENERATED BY TUMOR-ACTIVATED HEPATIC SINUSOIDAL ENDOTHELIAL CELLS
09:50 Kellie A. Charles, London, UK CLINICAL INVESTIGATION OF THE BIOLOGICAL ACTIVITY OF AN ANTI-TNF- ALPHA MONOCLONAL ANTIBODY, INFLIXIMAB, IN THE TUMOUR MICROENVIRONMENT OF PATIENTS WITH ADVANCED OVARIAN CANCER
10:02 Laura F. Gibson, Morgantown, WV, USA MICROENVIRONMENT SUPPORT OF A UNIQUE LEUKEMIC CELL POPULATION WITH STEM CELL PROPERTIES
10:14 Sumanta Goswami, New York, NY, USA TUMOR MICROENVIRONMENT INDUCED INVASIVE AND DRUG RESISTANT BREAST CANCER CELLS
10:26 Fabio Pastorino, Genoa, Italy TARGETING LIPOSOMAL CHEMOTHERAPY VIA BOTH TUMOR CELL-SPECIFIC AND TUMOR VASCULATURE-SPECIFIC LIGANDS POTENTIATES THERAPEUTIC EFFICACY
10:38 Bratko Filipič, Ljubljana, Slovenia EXTRACELLULAR Ca++ IONS AFFECT THE CYTOCIDAL AND ANTIPROLIFERATIVE ACTIVITY OF HUMAN INTERFERON α
10:50-11:30 – Coffee
Symposium IV – Local Expressions of Inflammation – Sala Verde
Session dedicated to the memory of Professor Shraga Segal
Chairperson: Ron Apte
11:30 Eli Pikarsky, Jerusalem, Israel NF-κB IN HEPATOCARCINOGENESIS - LESSONS FROM DIFFERENT ANIMAL MODELS
11:50 Adi Zipin-Roitman, Tel-Aviv, Israel CXCL10 PROMOTES INVASIVE-RELATED PROPERTIES IN COLORECTAL CARCINOMA CELLS
12:02 Venkateshwar G. Keshamouni, Ann Arbor, MI, USA TGF-BETA-INDUCED IRAK-M EXPRESSION IN TUMOR ASSOCIATED MACROPHAGES REGULATES LUNG TUMOR PROGRESSION
12:14 Nicholas J. Clemons, Cambridge, UK THE LUMINAL MICROENVIRONMENT IN THE DEVELOPMENT OF OESOPHAGEAL ADENOCARCINOMA
12:26 Sandra O. Gollnick, Buffalo, NY, USA NEUTROPHILS PLAY A CRITICAL ROLE IN DEVELOPMENT OF TUMOR SPECIFIC CD8+ T CELL RESPONSES
12:38 Christoph Peters, Freiburg, Germany INVASION AND METASTASIS OF MAMMARY CANCER DEPENDS ON TUMOR- AND STROMA-CELL DERIVED CYSTEINE CATHEPSINS
12:50 Gwendal Lazennec, Montpellier, France INTERLEUKIN-8 (IL-8) IS AN IMPORTANT MARKER FOR BREAST CANCER METASTASIS
13:02 Janine T. Erler, Stanford, CA, USA TUMOR-SECRETED LYSYL OXIDASE IS REQUIRED FOR METASTATIC NICHE
13:14 Ioannis Stasinopoulos, Baltimore, MD, USA LOSS OF COX-2 LIMITS TUMOR GROWTH AND INHIBITS METASTASIS
Symposium V – Signaling and Regulation of Gene Expression I – Auditorium
Chairperson: Avraham Raz
11:30 Antonella Naldini, Siena, Italy HYPOXIA INDUCES THE EXPRESSION OF PROTEASE-ACTIVATED RECEPTOR (PAR)-1 THROUGH THE HYPOXIC INDUCIBLE FACTOR (HIF)-1Α IN BREAST CANCER CELLS
11:50 Marcelo Ehrlich, Tel-Aviv, Israel PHOSPHOLIPASE D IS AN EFFECTOR AND REGULATOR OF THE EPITHELIAL TO MESENCHYMAL TRANSITION OF MOUSE MAMMARY TUMOR CELLS
12:10 Robert Gatenby, Tucson, AZ, USA THE ROLES OF MICROENVIRONMENTAL HYPOXIA AND ACIDOSIS IN CARCINOGENESIS
12:22 Hongyan Cui, Sapporo, Japan ENHANCED EXPRESSION OF ASPARAGINE SYNTHETASE UNDER GLUCOSE-DEPRIVED CONDITIONS PROTECTS PANCREATIC CANCER CELLS FROM APOPTOSIS INDUCED BY GLUCOSE DEPRIVATION AND CISPLATIN
12:34 Elena Tirrò, Catania, Italy SILENCING OF BCR-ABL/JAK2-INDUCED SURVIVIN SENSITIZES IMATINIB RESISTANT CML CELLS TO HYDROXYUREA
12:46 Maria Grazia Borrello, Milan, Italy ONCOGENE-INDUCED PROMOTION OF AN INFLAMMATORY MICROENVIRONMENT: THE THYROID MODEL
12:58 Carlton D. Donald, Charleston, SC, USA THE PAX2 ONCOGENE MAY PROMOTE CANCER CELL SURVIVAL THROUGH THE SUPPRESSION OF IMMUNE-MEDIATED RECOGNITION AND DESTRUCTION: NEW INSIGHT TO A NOVEL TARGET FOR CANCER THERAPY
13:10 Medhat Shehata, Vienna, Austria LYMPHOID MICROENVIRONMENT SUPPORTS SURVIVAL OF BCLL CELLS: ROLE OF TGF-BETA AND PI3-K/Akt PATHWAY
13:22 Andrei Thomas-Tikhonenko, Philadelphia, PA, USA c-Myc-REGULATED MicroRNAs PROMOTE TUMOR GROWTH THROUGH EFFECTS ON ANGIOGENESIS AND TUMOR MICROENVIRONMENT
Afternoon free
Friday, March 9, 2007
08:30-10:00 – Poster Session – Auditorium
10:00-10:30 – Coffee
Symposium VI - Signaling and Regulation of Gene Expression II - Auditorium
Chairperson: Adriana Albini
10:30 Rachel Bar-Shavit, Jerusalem, Israel PAR1 IN MALIGNANT AND PHYSIOLOGICAL INVASION: IDENTIFICATION OF LINKERS TO BETA-CATENIN, PROMOTER SIGNATURES & SILENCING MODALITIES
10:50 Zaidoun Salah, Jerusalem, Israel TRANSCRIPTIONAL REGULATIONS OF hPAR1 IN PROSTATE CARCINOMA
11:02 Andrei V. Bakin, Buffalo, NY, USA NEW INSIGHTS IN THE MECHANISMS OF THE TGF-BETA EFFECTS ON TUMOR MICROENVIRONMENT AND THE METASTATIC POTENTIAL
11:14 Ugo Cavallaro, Milan, Italy THE NCAM/FGFR COMPLEX: A NOVEL CROSS-TALK INVOLVED IN METASTASIS?
11:26 Cameron N. Johnstone, Philadelphia, PA, USA PARVIN-BETA, A NEGATIVE REGULATOR OF INTEGRIN-LINKED KINASE SIGNALING, MODULATES CELLULAR INVASION AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA ACTIVITY
11:38 Manikuntala Kundu, Kolkata, India HELICOBACTER PYLORI-MEDIATED SIGNALING IN GASTRIC EPITHELIAL CELLS AND ITS IMPLICATIONS IN HELICOBACTERMEDIATED GASTRIC ULCER AND GASTRIC CARCINOMA
11:50 Tiziana Triulzi, Milan, Italy RELEVANCE OF BREAST CARCINOMA EXTRACELLULAR MATRIX COMPOSITION IN DRUG SENSITIVITY
12:02 Rosaria Orlandi, Milan, Italy EXREACELLULAR MATRIX (ECM) - DRIVEN ANALYSIS OF GENE EXPRESSION DATA FROM BREAST AND OVARIAN CANCER
Symposium VII – Tumor- Stroma Interactions – Sala Verde
Chairperson: Israel Vlodavsky
10:30 Maty Tzukerman, Haifa, Israel THE HUMAN EMBRYONIC STEM CELL-DERIVED MICROENVIRONMENT HAS THE POTENTIAL TO UNVEIL CANCER SUBPOPULATIONS THAT DO NOT DEVELOP INTO TUMORS IN CONVENTIONAL MURINE XENOGRAFTS
10:50 Edna Cukierman, Philadelphia, PA, USA ALTERED 3D-ADHESIONS SUPPORT A Src/FAK DEPENDENT INTEGRIN CROSSTALK DURING STROMAGENESIS
11:10 Luuk J.A.C. Hawinkels, Leiden, The Netherlands
MATRIX METALLOPROTEINASE-9 (MMP-9) MEDIATES TUMOUR CELL VEGF RELEASE INDUCING ENDOTHELIAL CELL ANGIOGENESIS
11:22 Zoi Diamantopoulou, Patras, Greece P10, A PEPTIDE WITH ANTI TUMOUR BIOLOGICAL ACTIONS
11:34 Iker Badiola, Leioa, Spain IMPLICATION OF DISCOIDIN DOMAIN RECEPTORS IN THE ACTIVATION OF HEPATIC STELLATE CELLS DURING LIVER METASTASIS
11:46 Amitava Chatterjee, Kolkata, India CULTURE OF HUMAN BREAST CANCER CELLS (MCF-7) IN PRESENCE OF FIBRONECTIN IN SERUM FREE MEDIUM ACTIVATES MMP-2 & MMP-9
11:58 Susan Deutscher, Columbia, MO, USA NOVEL IN VIVO TUMOR-IMAGING AND TARGETING AGENTS USING GALECTIN-3 PEPTIDE AGONISTS
12:10 Delia Mezzanzanica, Milan, Italy DELOCALIZATION OF ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE FROM THE CELL MEMBRANE IS A MOLECULAR PREDICTOR OF SURVIVAL IN ADVANCED OVARIAN CARCINOMA PATIENTS
12:30-14:00 – Business Meeting and Lunch -Auditorium
Plenary Session V - Tumor-Endothelium Interactions - Auditorium
Chairperson: Kari Alitalo
14:00 Eli Keshet, Jerusalem, Israel VEGF-INDUCED RECRUITMENT OF PRO-ANGIOGENIC CIRCULATING CELL
14:25 Jaques Huot, Québec, QC, Canada BI-DIRECTIONAL SIGNALLING INDUCED BY E-SELECTIN AND DEATH RECEPTOR-3 IN COLON CANCER METASTASIS
Plenary session VI – Dangerous Liaisons in the Tumor Microenvironment -
Auditorium
Chairperson: Eiichi Tahara
14:50 Yves DeClerck, Los Angeles, CA, USA CONTRIBUTION OF BONE MARROW MESENCHYMAL CELLS TO BONE METASTASIS
15:15 Kelvin P. Lee, Buffalo, NY, USA DENDRITIC CELLS SUPPORT MULTIPLE MYELOMA CELL SURVIVAL THROUGH CD28 RECEPTOR ACTIVATION
15:40 Neta Erez, San Francisco, CA, USA ROLES OF CARCINOMA ASSOCIATED FIBROBLASTS IN MOUSE MODELS OF CERVICAL AND SKIN CARCINOGENESIS
16:05-16:30 – Coffee
Plenary session VII – Targeting the Tumor Microenvironment: Preclinical and Clinical Trials I -Auditorium
Session dedicated to the memory of Mary A. Pikovski
Chairperson: Yves DeClerck
16:30 Alexander Levitzki, Jerusalem, Israel ERADICATING EGFR OVER-EXPRESSING TUMORS BY TARGETED DELIVERY OF PolyIC
16:55 Eiichi Tahara, Hiroshima, Japan A MODEL FOR COMPREHENSIVE PREVENTION OF GASTRIC CANCER BASED ON NOVEL BIOMARKERS AND LONGITUDINAL HEALTH DATABASE OF ATOMIC BOMB SURVIVORS
17:20 Adriana Albini, Milan, Italy THE MICROENVIRONMENT AS A TARGET OF CANCER CHEMOPREVENTION
17:45 Yona Keisari, Tel Aviv, Israel IN SITU DESTRUCTION OF SOLID MALIGNANT CANCER BY COMBINATION RADIO-PHYSICO-CHEMICAL TREATMENTS AND ACTIVATION OF ANTI-TUMOR IMMUNITY
18:10 Benjamin Bonavida, Los Angeles, CA, USA YING YANG 1 (YY1) AND RAF KINASE INHIBITOR PROTEING (RKIP) REGULATE TUMOR CELL RESISTANCE TO APOPTOSIS BY CHEMO-IMMUNOTHERAPY
20:30 -Farewell Evening
Saturday, March 10, 2007
Plenary session VIII – Targeting the Tumor Microenvironment: Preclinical and Clinical Trials II -Auditorium
Chairperson: Fernando Vidal-Vanaclocha
08:30 Michael R. Shurin, Pittsburgh, PA, USA DENDRITIC CELLS IN THE TUMOR MICROENVIRONMENT: FROM EXPERIMENTS TO THERAPY
08:55 Fernando Vidal-Vanaclocha, Bilbao, Viscaya, Spain MICROENVIRONMENT-DEPENDENT GENE EXPRESSION PATTERNS IN HEPATIC METASTASES FROM COLON CARCINOMA PATIENTS. PHARMACOGENOMIC IMPLICATIONS
09:20 Daniel Zagury, Paris, France THE UTILITY OF TNFα VACCINATION IN THE PREVENTION OF CACHEXIA AT TERMINAL STAGES OF CANCER
09:45 Ruth Lupu, Evanston, IL, USA BLOCKADE OF A KEY MOLECULAR-ACTIVATION SWITCH IN THE SUB-DOMAIN III OF ER2 EXTRACELLULAR DOMAIN (ECD) RECAPITULATES THE ANTI-HER2 ACTIONS OF TRASTUZUMAB, PERTUZUMAB AND LAPATINIB
10:10 Bonnie Hylander, Buffalo, NY, USA DEFINING THE ANTI-TUMOR EFFICACY OF Apo2L/TRAIL AGAINST PATIENT-DERIVED PANCREATIC TUMOR XENOGRAFTS IN SCID MICE
10:35 Adriana Haimovitz-Friedman, New York, NY, USA bFGF AND VEGF INHIBIT RADIATION-INDUCED APOPTOSIS OF ENDOTHELIAL CELLS BY INHIBITING ACID SPHINGOMYELINASE ACTIVITY
11:00-11:30 – Coffee
Plenary session IX – The Tumor Microenvironment Drives Tumor Progression- Auditorium
Chairperson: Suresh Mohla
11:30 Eva Klein, Stockholm, Sweden CONTRIBUTION OF EBV INFECTION AND THE MICROENVIRONMENT TO THE DEVELOPMENT OF HODGKIN’S AND NK-LYMPHOMAS
11:55 Catherine Sautès-Fridman, Paris, France TRAF4 OVEREXPRESSION IS A COMMON CHARACTERISTIC OF HUMAN CARCINOMA
12:20 Yves St-Pierre, Laval, QC, Canada GALECTIN-7 PLAYS A CENTRAL ROLE IN TUMORIGENESIS
12:45 Judith Leibovici, Tel Aviv, Israel THE AGED ORGANISM AS A MALIGNANCY REDUCING MICROENVIRONMENT
13:10 Jan Zeromski, Poznan, Poland EXPRESSION OF TOLL-LIKE RECEPTORS IN THE MICROENVIRONMENT OF LARYNGEAL CARCINOMA
13:35 -Adjourn